BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 1786916)

  • 1. Elevated proto-oncogene and collagen mRNA expression in PVR retinas.
    Hollborn M; Faude F; Wiedemann P; Kohen L
    Graefes Arch Clin Exp Ophthalmol; 2003 May; 241(5):439-46. PubMed ID: 12698259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular neovascularization: clarifying complex interactions.
    Neely KA; Gardner TW
    Am J Pathol; 1998 Sep; 153(3):665-70. PubMed ID: 9736014
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin: a new attachment protein in preretinal traction membranes.
    Weller M; Esser P; Bresgen M; Heimann K; Wiedemann P
    Eur J Ophthalmol; 1992; 2(1):10-4. PubMed ID: 1353387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contractile elements in proliferative retinal diseases].
    Molitor R; Esser P; Weller M; Wiedemann P; Heimann K
    Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1991; 88(4):337-40. PubMed ID: 1786916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proliferative vitreoretinopathy: new discoveries in pathophysiology and therapy].
    Wiedemann P; Weller M; Heimann K
    Klin Monbl Augenheilkd; 1990 Nov; 197(5):355-61. PubMed ID: 2290290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin in vitreoretinal diseases.
    Yoshida S; Nakama T; Ishikawa K; Nakao S; Sonoda KH; Ishibashi T
    Cell Mol Life Sci; 2017 Dec; 74(23):4329-4337. PubMed ID: 28913545
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.